0001144204-17-009663.txt : 20170216
0001144204-17-009663.hdr.sgml : 20170216
20170216191327
ACCESSION NUMBER: 0001144204-17-009663
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20170210
FILED AS OF DATE: 20170216
DATE AS OF CHANGE: 20170216
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: DERMA SCIENCES, INC.
CENTRAL INDEX KEY: 0000892160
STANDARD INDUSTRIAL CLASSIFICATION: SURGICAL & MEDICAL INSTRUMENTS & APPARATUS [3841]
IRS NUMBER: 232328753
STATE OF INCORPORATION: PA
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 214 CARNEGIE CENTER, SUITE 300
CITY: PRINCETON
STATE: NJ
ZIP: 08540
BUSINESS PHONE: 6095144744
MAIL ADDRESS:
STREET 1: 214 CARNEGIE CENTER, SUITE 300
CITY: PRINCETON
STATE: NJ
ZIP: 08540
FORMER COMPANY:
FORMER CONFORMED NAME: DERMA SCIENCES INC
DATE OF NAME CHANGE: 19940513
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: MOUSSA ROBERT G
CENTRAL INDEX KEY: 0001012788
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-13070
FILM NUMBER: 17619403
MAIL ADDRESS:
STREET 1: 1375 KINGS HIGHWAY EAST
CITY: FAIRFIELD
STATE: CT
ZIP: 06824
4
1
v459886_form4.xml
FORM 4
X0306
4
2017-02-10
0
0000892160
DERMA SCIENCES, INC.
DSCI
0001012788
MOUSSA ROBERT G
C/O DERMA SCIENCES, INC.,
214 CARNEGIE CENTER, SUITE 300
PRINCETON
NJ
08540
1
0
0
0
Common Stock
2017-02-10
4
M
0
4375
6.40
A
85771
D
Common Stock
2017-02-10
4
F
0
4000
7.00
D
81771
D
Stock Option (right to buy)
6.40
2017-02-10
4
M
0
4375
0
D
2007-03-01
2017-02-22
Common Stock
4375
0
D
Shares delivered in connection with the cashless exercise of 4,375 options, previously granted pursuant to the issuer's stock option plan, at an exercise price of $6.40, as reported herein.
A total of 35,000 of the options were granted pursuant to the issuer's stock option plan on March 1, 2007. Options for 25% of the shares vested immediately and options for the remaining shares vested at the rate of 25% per year starting on February 22, 2008. The revised total of 4,375 options reflects the issuer's 1-for-8 reverse split effective January 1, 2010.
The options were originally granted in consideration of the reporting person's services to the issuer and without payment of cash.
/s/ Robert G. Moussa
2017-02-16